Literature DB >> 16255688

Assessment of age-related maculopathy using subjective vision tests.

Jan Lovie-Kitchin1, Beatrix Feigl.   

Abstract

This paper reviews non-standard, clinical vision tests that may be used to detect the earliest visual loss in age-related maculopathy (ARM), before fundus changes are detected. We recommend a clinical test battery for all patients aged 60 years and older, comprising low luminance/low contrast (SKILL) VA or low contrast VA, desaturated D-15 colour vision assessment, flicker perimetry, glare recovery and dark adaptation if possible, together with conventional assessments of case history, ophthalmoscopy and high contrast visual acuity (VA) for the detection and diagnosis of ARM. Reading rate is also discussed as a potential indicator of early visual loss. For monitoring the progressive visual loss in age-related macular degeneration (AMD) and determining the requirements for optometric vision rehabilitation, we recommend more conventional clinical vision tests of distance and near visual acuity, reading rate, the effects of varying illumination and a functional central visual field assessment.

Entities:  

Mesh:

Year:  2005        PMID: 16255688     DOI: 10.1111/j.1444-0938.2005.tb06713.x

Source DB:  PubMed          Journal:  Clin Exp Optom        ISSN: 0816-4622            Impact factor:   2.742


  13 in total

1.  Comparison of Visual Function in Older Eyes in the Earliest Stages of Age-related Macular Degeneration to Those in Normal Macular Health.

Authors:  Cynthia Owsley; Carrie Huisingh; Mark E Clark; Gregory R Jackson; Gerald McGwin
Journal:  Curr Eye Res       Date:  2015-03-24       Impact factor: 2.424

2.  Association between hearing and vision impairments in older adults.

Authors:  Marilyn E Schneck; Lori A Lott; Gunilla Haegerstrom-Portnoy; John A Brabyn
Journal:  Ophthalmic Physiol Opt       Date:  2011-10-15       Impact factor: 3.117

3.  Critical flicker-fusion frequency in age-related macular degeneration.

Authors:  Mathias Maier; Thomas Groneberg; Holger Specht; Chris Patrick Lohmann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-03       Impact factor: 3.117

4.  Comparison of panel D-15 tests in a large older population.

Authors:  Marilyn E Schneck; Gunilla Haegerstrom-Portnoy; Lori A Lott; John A Brabyn
Journal:  Optom Vis Sci       Date:  2014-03       Impact factor: 1.973

5.  Parafoveal letter recognition at reduced contrast in normal aging and in patients with risk factors for AMD.

Authors:  Gesa Astrid Hahn; Andre Messias; Manfred Mackeben; Klaus Dietz; Karin Horwath; Lea Hyvärinen; Markku Leinonen; Susanne Trauzettel-Klosinski
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-08-28       Impact factor: 3.117

6.  The flicker Pupil Light Response (fPLR).

Authors:  Prakash Adhikari; Beatrix Feigl; Andrew J Zele
Journal:  Transl Vis Sci Technol       Date:  2019-10-17       Impact factor: 3.283

Review 7.  Early detection of age related macular degeneration: current status.

Authors:  Roy Schwartz; Anat Loewenstein
Journal:  Int J Retina Vitreous       Date:  2015-12-01

8.  Relationships of orientation discrimination threshold and visual acuity with macular lesions in age-related macular degeneration.

Authors:  Haojie Fu; Bin Zhang; Jianliang Tong; Harold Bedell; Hecheng Zhang; Yating Yang; Chaochao Nie; Yingdong Luo; Xiaoling Liu
Journal:  PLoS One       Date:  2017-09-18       Impact factor: 3.240

9.  Simple Vision Function Tests that Distinguish Eyes with Early to Intermediate Age-related Macular Degeneration.

Authors:  Lori A Lott; Marilyn E Schneck; Gunilla Haegerstrom-Portnoy; Susan Hewlett; Natalie Stepien-Bernabe; Bonnie M Gauer; Ali Zaidi; Arthur D Fu; John A Brabyn
Journal:  Ophthalmic Epidemiol       Date:  2020-08-12       Impact factor: 1.648

Review 10.  CURRENT CONCEPTS AND MODALITIES FOR MONITORING THE FELLOW EYE IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: An Expert Panel Consensus.

Authors:  Tien Yin Wong; Paolo Lanzetta; Francesco Bandello; Bora Eldem; Rafael Navarro; Monica Lövestam-Adrian; Anat Loewenstein
Journal:  Retina       Date:  2020-04       Impact factor: 3.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.